Covance (CVD)

46.87 +0.66  +1.43%  Feb 08, 1:25PM Go Pro
Watch
View Full Chart CVD Price Chart

Key Stats

Market Cap 2.85B
Revenue Growth 12.11%
Profit Margin 3.63%
Earnings Yield 4.63%
Dividend Yield 0.00%
Earnings Per Share TTM 2.17
PE Ratio 21.60
Price / Sales Ratio 1.27
52 Week High 63.86
52 Week Low 42.02
Beta 1.08
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

Feb 02 [$$] Potential M&A Targets in Contract Research
Feb 01 WuXi Profit Margins Dwarfing U.S. Lead China’s Drug Deal Targets: Real M&A
Jan 30 HIGH $PUT VOLU $BRKR 68750% $CTIC 7656% $TNB 7405% $OPK 3805% $GTXI 3440% $CVD 2731% $XBI 2482% $IFF 2423% $PBY 2394% $LAMR 2179% by livevol_pro
Jan 30 HIGH $PUT VOLU $BRKR 68750% $CTIC 7616% $TNB 5636% $OPK 3089% $XBI 2467% $CVD 2397% $GTXI 2267% $LAMR 2128% $KKR 2109% $FCN 1614% by livevol_pro
Jan 27 U.S. Companies Issuing Profit Outlooks for the Week of Jan. 27
Jan 27 Charges Spoil Covance's 4Q
Jan 27 Charges Spoil Covance's 4Q - Analyst Blog Zacks
Jan 27 On The Fly: Analyst Downgrade Summary
Jan 27 UPDATE: Citigroup Downgrades Covance to Neutral Benzinga
Jan 27 Citi Downgrades Covance (CVD) to Neutral Street Insider
Jan 26 $CVD http://stks.co/26d8 short by xpertstocktrader
Jan 26 $CVD New 52 Week Low - Crossed daily lows support. Next support 42.07 from 9/29/2010. by TradeIdeasQuant
Jan 26 Earnings/news gap down: $SNDK $CVD $LRCX $EFSC $PCP $POT $CRR $ETFC $VAR $UA $ETN $MKC $CL $T $TZOO $CY $MWW by TER_Intraday

Profile

Exchange: NYSE       Sector: Healthcare       Industry: Medical Laboratories & Research

Covance, Inc., formerly Corning Incorporated, with headquarters in Princeton, New Jersey, USA, is a contract research organization, providing drug development and animal testing services. According to its website, it is one of the largest companies of its kind in the world, with annual revenues greater than $2 billion, operations in more than 60 countries, and over 11,000 employees worldwide. It provides the world's largest central laboratory network, and employs a global team of clinical-trial professionals and cardiac-safety experts. It became a publicly traded company after being spun off by Corning, Inc., in 1997. The company was founded in 1987.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Covance is down N/A over the last year vs S&P 500 Total Return up N/A, PAREXEL International Corporation up N/A, and Icon down N/A.

  • CVD Total Returns
  • ^SPXTR Total Returns
  • PRXL Total Returns
  • ICLR Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring CVD

Did Covance make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

CVD Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
CVD 46.87 0.66 1.43% 2.81B
PUK 23.14 -0.07 -0.30% 29.57B
ITA 66.81 0.35 0.53%
APH 54.81 -0.06 -0.11% 9.09B
AFT 17.49 0.04 0.23%
UPI 3.72 0.18 5.08% 73.67M
RSP 50.49 0.03 0.06%
ADI 39.98 0.31 0.78% 11.88B
ETF 19.30 -0.04 -0.21%
FCL 27.36 0.68 2.55%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close